179 related articles for article (PubMed ID: 27146742)
1. Occurrence of myelodysplasia/acute myeloid leukemia 'on therapy' in two patients with acute promyelocytic leukemia.
Chelghoum Y; Plesa A; Ducastelle S; Elhamri M; Thomas X
Indian J Cancer; 2016; 53(1):59-60. PubMed ID: 27146742
[No Abstract] [Full Text] [Related]
2. Therapy-related MDS and AML in acute promyelocytic leukemia.
Andersen MK; Pedersen-Bjergaard J
Blood; 2002 Sep; 100(5):1928-9; author reply 1929. PubMed ID: 12211197
[No Abstract] [Full Text] [Related]
3. Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL).
Garcia-Manero G; Kantarjian HM; Kornblau S; Estey E
Leukemia; 2002 Sep; 16(9):1888. PubMed ID: 12200720
[No Abstract] [Full Text] [Related]
4. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
5. [Current therapy for acute myeloid leukemia and acute promyelocytic leukemia].
Miyawaki S
Rinsho Ketsueki; 2014 Jan; 55(1):31-41. PubMed ID: 24492035
[No Abstract] [Full Text] [Related]
6. Updates on the treatment of acute promyelocytic leukemia.
Tallman MS
Clin Adv Hematol Oncol; 2010 Feb; 8(2):89-90. PubMed ID: 20386527
[No Abstract] [Full Text] [Related]
7. Central nervous system relapse in acute promyelocytic leukemia.
Colovic N; Bogdanovic A; Miljic P; Jankovic G; Colovic M
Am J Hematol; 2002 Sep; 71(1):60-1. PubMed ID: 12221680
[No Abstract] [Full Text] [Related]
8. Combination of decitabine, idarubicin, cytarabine, and G-CSF (DIAG) regimen for the treatment of high-risk myelodysplastic syndrome and acute myeloid leukemia.
Zhang X; Guo X
Ann Hematol; 2019 Sep; 98(9):2223-2225. PubMed ID: 30980106
[No Abstract] [Full Text] [Related]
9. Interferon may reduce minimal residual disease of acute promyelocytic leukemia.
Egyed M; Rumi G; Boros B; Páldi-Haris P; Földi J
Leukemia; 2000 Jun; 14(6):1153. PubMed ID: 10865982
[No Abstract] [Full Text] [Related]
10. A single-center, retrospective study of management and outcome of 45 elderly AML patients, diagnosed in 2001.
Alymara V; Tzouvara E; Vartholomatos G; Chaidos A; Tsiara S; Bourantas KL
J Exp Clin Cancer Res; 2004 Sep; 23(3):447-54. PubMed ID: 15595635
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of high-risk acute promyelocytic leukemia in very elderly patients using all-trans retinoic acid plus reduced-dose idarubicin.
Fujisawa T; Takeda J; Aoki K; Ishikawa T
Ann Hematol; 2014 Sep; 93(9):1621-3. PubMed ID: 24399307
[No Abstract] [Full Text] [Related]
12. Acute pancreatitis during all-trans-retinoic acid treatment for acute promyelocytic leukemia in a patient without overt hypertriglyceridemia.
Teng HW; Bai LY; Chao TC; Wang WS; Chen PM
Jpn J Clin Oncol; 2005 Feb; 35(2):94-6. PubMed ID: 15709095
[TBL] [Abstract][Full Text] [Related]
13. Idarubicin in acute leukemias: experience of the Italian Cooperative Group GIMEMA.
Petti MC; Mandelli F
Semin Oncol; 1989 Feb; 16(1 Suppl 2):10-5. PubMed ID: 2928805
[No Abstract] [Full Text] [Related]
14. AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation.
Breccia M; Cimino G; Alimena G; De Carolis S; Lo Coco F; Mandelli F
Haematologica; 2002 Feb; 87(2):ELT12. PubMed ID: 11836189
[No Abstract] [Full Text] [Related]
15. Automated differential counts in acute promyelocytic leukemia patients may be misleading.
Kapelushnik J; Kafka M; Moser A; Yermiahu T
Med Pediatr Oncol; 2002 Apr; 38(4):269-70. PubMed ID: 11920794
[No Abstract] [Full Text] [Related]
16. High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia.
Schlenk RF; Germing U; Hartmann F; Glasmacher A; Fischer JT; del Valle y Fuentes F; Götze K; Pralle H; Nerl C; Salwender H; Grimminger W; Petzer A; Hensel M; Benner A; Zick L; Döhner K; Fröhling S; Döhner H;
Leukemia; 2005 Jun; 19(6):978-83. PubMed ID: 15843821
[TBL] [Abstract][Full Text] [Related]
17. Could ATRA/Idarubicin treatment of acute promyelocytic leukemia induce the appearance of new clonal cytogenetic abnormalities in patients in complete remission?
Mallo M; Salido M; Espinet B; Cervera J; Canellas A; Pajuelo JC; Pedro C; Florensa L; Sanz MA; Solé F
Leuk Res; 2007 Sep; 31(9):1315-7. PubMed ID: 17092559
[No Abstract] [Full Text] [Related]
18. Idarubicin plus continuous-infusion high-dose cytarabine as treatment for patients with acute myelogenous leukemia or myelodysplastic syndrome.
Estey EH; Kantarjian H; Keating M
Semin Oncol; 1993 Dec; 20(6 Suppl 8):1-5. PubMed ID: 8290966
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association?
Parajuli R; Altman J; Kuzel T; Perdekamp M; Tallman M
Am J Hematol; 2010 Oct; 85(10):829. PubMed ID: 20721888
[No Abstract] [Full Text] [Related]
20. Relapse of acute promyelocytic leukemia presenting as granulocytic sarcoma in the hip.
Agarwal N; Tepe EM; Mishra A; Ward JH
Ann Hematol; 2006 Oct; 85(10):741-2. PubMed ID: 16718497
[No Abstract] [Full Text] [Related]
[Next] [New Search]